• East Afr Med J · Feb 1993

    Multicenter Study Clinical Trial

    Evaluation of diprivan as an intravenous anaesthetic induction agent: experiences in Nairobi, Kenya.

    • P O Huma.
    • Department of Surgery, Faculty of Medicine, University of Nairobi, Kenya.
    • East Afr Med J. 1993 Feb 1; 70 (2): 101-3.

    AbstractDiprivan in its emulsion formulation as an intravenous induction agent was studied in 125 patients undergoing general anaesthesia for short duration, minor procedures, at Kenyatta National Hospital, Nairobi, Kenya. The drug was found to be effective as it caused loss of consciousness in all the studied patients within 40 seconds when injected intravenously. The induction period was associated with pain at injection site in 31.2%, some muscle movements in 15.2% and hiccups in 8.8% of all the cases. There was a significant fall in mean arterial blood pressure in all the cases at two minutes after induction of anaesthesia with no observed concomitant changes in pulse rate.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.